May 31, 2001UDL Laboratories Inc. Recalls
IL (SafetyAlerts) - The Food and
Drug Administration (FDA) said today that UDL Laboratories, Inc. is recalling certain Perphenazine Tablets because
of discoloration of tablets prior to expiry.
This is the first public notice of
this Class III
recall issued by FDA.
Perphenazine Tablets, USP (Gray)
a) 2 mg. tablets - NDC 51079-738-20 Recall #D-215-1;
b) 4 mg. tablets - NDC 51079-739-20 Recall #D-216-1;
c) 8 mg. tablets - NDC 51079-740-20 Recall #D-217-1;
d) 16 mg. tablets -NDC 51079-823-20 Recall #D-218-1.
Packaged in unit dose blisters 10 unit dose
tablets per card, 10 cards per shelf carton.
a) lots 0B224, 0J900, 1A680;
b) lots 0C382, 0J891, 0S474, 1B909;
c) lots 0A067, 0P287;
d) lots 0B119, 0S399.
Zenith Goldline Pharmaceuticals, Northvale, NJ.
UDL Laboratories, Inc., Rockford, IL, by letter dated 5/11/01. Firm-initiated recall
a)3939; b) 3894; c) 3541; d) 1183.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafetyAlerts subscribers May 31,
2001. For more information regarding the SafetyAlerts free email alert service
please click here.